BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7370965)

  • 1. Cystadenocarcinoma of the ovary in a 4-year-old: benign transformation during therapy.
    Hong SJ; Lurain JR; Tsukada Y; Piver MS; Humbert JR; Freeman AI
    Cancer; 1980 Apr; 45(8):2227-30. PubMed ID: 7370965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-look laparotomy in the management of epithelial ovarian carcinoma: an evaluation of fifty cases.
    Luesley DM; Chan KK; Fielding JW; Hurlow R; Blackledge GR; Jordon JA
    Obstet Gynecol; 1984 Sep; 64(3):421-6. PubMed ID: 6462573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma.
    Puls LE; Powell DE; DePriest PD; Gallion HH; Hunter JE; Kryscio RJ; van Nagell JR
    Gynecol Oncol; 1992 Oct; 47(1):53-7. PubMed ID: 1427402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian mucinous cystadenocarcinoma with sarcoma-appearing mural nodule of anaplastic carcinoma.
    Tsuruchi N; Kaku T; Kinoshita H; Amada S; Saito T; Kamura T; Tsukamoto N; Nakano H
    Gynecol Oncol; 1993 Aug; 50(2):259-63. PubMed ID: 8375741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucinous cystadenocarcinoma in a premenarchal girl.
    Hernandez E; Rosenshein NB; Parmley TH
    South Med J; 1982 Oct; 75(10):1265-7. PubMed ID: 7123301
    [No Abstract]   [Full Text] [Related]  

  • 6. [Second-look laparotomy in epithelial ovarian cancer: an evaluation of 23 cases].
    Liu LY
    Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):77-9, 123. PubMed ID: 2364794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphological characteristics of serous ovarian adenocarcinomas after chemotherapy].
    Serov SF; Irzhanov SI
    Vopr Onkol; 1980; 26(3):37-40. PubMed ID: 7368655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of various factors on the results of chemotherapy in patients with recurrent ovarian serous cystadenocarcinoma].
    Dzhilavian GA; Vinokurov VL
    Vopr Onkol; 1984; 30(3):16-21. PubMed ID: 6424327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The silent killer: treatment of a patient by the oncological team].
    Lindert AC; Barents JW; Pinedo HM
    Ned Tijdschr Geneeskd; 1978 Jan; 122(3):65-8. PubMed ID: 622198
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-surgical aspects of ovarian cancer.
    Lancet; 1994 Feb; 343(8893):335-40. PubMed ID: 7905150
    [No Abstract]   [Full Text] [Related]  

  • 11. Second-look operations in the planned management of advanced ovarian carcinoma.
    Raju KS; McKinna JA; Barker GH; Wiltshaw E; Jones JM
    Am J Obstet Gynecol; 1982 Nov; 144(6):650-4. PubMed ID: 7137248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer.
    Everett EN; French AE; Stone RL; Pastore LM; Jazaeri AA; Andersen WA; Taylor PT
    Am J Obstet Gynecol; 2006 Aug; 195(2):568-74; discussion 574-6. PubMed ID: 16890558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged intake of chlorambucil for ovarian cancer.
    Khalil AM; Khatib RA; Shamseddine AI; Sharara NH; Seoud MA
    Eur J Obstet Gynecol Reprod Biol; 1995 May; 60(1):85-6. PubMed ID: 7635238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serous papillary adenocarcinoma of the ovary in a Nigerian child.
    Akinola O; Okonofua FE; Odesanmi WO; Oshinaike AI
    Trop Geogr Med; 1988 Jul; 40(3):251-3. PubMed ID: 3188217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
    Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
    Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.
    Morrison J; Swanton A; Collins S; Kehoe S
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005343. PubMed ID: 17943850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early detection of recurrence of ovarian carcinoma by immunoscintigraphy].
    Vuillez JP; Lumbroso D; Grelat A; Dieny A; Mousseau M; Bolla M; Bernard P
    Presse Med; 1992 Dec; 21(42):2060. PubMed ID: 1294981
    [No Abstract]   [Full Text] [Related]  

  • 18. [The therapeutic value of second-look laparotomy in advanced ovarian carcinoma].
    Schneider J; Martin M; Erasun F; Matia JC; Rodriguez-Escudero FJ
    Zentralbl Gynakol; 1988; 110(22):1443-8. PubMed ID: 3223119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-look laparotomy in managing epithelial ovarian carcinoma.
    Dauplat J; Ferriere JP; Gorbinet M; Legros M; Chollet P; Giraud B; Plagne R
    Cancer; 1986 Apr; 57(8):1627-31. PubMed ID: 3948133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case report of ovarian cancer stage Ia with micrometastasis of para-aortic lymph node].
    Adachi S; Noda T; Hirano Y; Katou Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Nov; 44(11):1459-62. PubMed ID: 1460366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.